What is the latest news on ZYXI stock?

SECago
Zynex Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

8-K - ZYNEX INC (0000846475) (Filer)

All ZYXI news

When does Zynex report earnings?

The latest Zynex earnings release came out on Nov 14, 2025: Zynex Sets Third Quarter 2025 Earnings Call. Before that, Zynex reported on Jul 31, 2025 and Apr 29, 2025.

ZYXI earnings history

Latest news

25 items

Zynex Inc. (ZYXI) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. There were no new wire items for ZYXI in the last 30 days. The most recent was published Dec 18, 2025.

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.

ZYXI FAQ

6 questions
  • What does Zynex Inc. do?
    Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company...
  • Where does ZYXI stock trade?
    Zynex Inc. (ZYXI) is listed on NASDAQ.
  • What sector and industry is ZYXI in?
    Zynex Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • What are analysts saying about ZYXI?
    Across the last 8 analyst actions on Zynex Inc., there were 2 upgrades and 3 downgrades. The most recent action was from Ladenburg Thalmann: Buy with a $3.70 price target on 2025-08-01.
  • What companies are similar to ZYXI?
    Notable peers in the same industry include ITGR (Integer Holdings Corporation), MDT (Medtronic plc.), INMD (InMode Ltd.), AXGN (Axogen Inc.), TMDX (TransMedics Group Inc.). Compare ZYXI side-by-side with any of them on Quantisnow.
  • How can I track ZYXI on Quantisnow?
    Quantisnow aggregates Zynex Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZYXI to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change